MariMed Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details Narrative)

Subsequent Events (Details Narrative)	1 Months Ended					12 Months Ended
Subsequent Events (Details Narrative)	Mar. 31, 2019 USD ($) ft²	Feb. 28, 2019 USD ($) $ / shares shares	Jan. 31, 2019 USD ($)	Dec. 31, 2018 USD ($) $ / shares	Aug. 31, 2018	Dec. 31, 2018 USD ($) $ / shares shares	Dec. 31, 2017 USD ($) $ / shares shares
Ownership percentage							100.00%
Lease term					10 years
Proceeds from issuance of promissory note						$ 3,206,338	$ 9,475,000
Number of common stock shares issued, values						31,821,001	6,578,000
Proceeds from warrant exercises						385,395
Proceeds from issuance of common stock						31,821,001	6,585,800
Principal amount				$ 7,495,000		7,495,000	2,300,000
Accrued interest				$ 95,000		$ 95,000	$ 312,000
Options One [Member]
Options to purchase shares of common stock \| shares						300,000	550,000
Subscriptions Receivable [Member]
Number of common stock shares issued \| shares						97,136
Minimum [Member]
Common stock price per share \| $ / shares				$ 0.50		$ 0.50	$ 0.18
Warrant exercise price per share \| $ / shares				0.20		0.20	0.40
Maximum [Member]
Common stock price per share \| $ / shares				0.65		0.65	0.50
Warrant exercise price per share \| $ / shares				$ 0.40		$ 0.40	$ 0.62
Subsequent Event [Member]
Proceeds from issuance of promissory note	$ 6,000,000
Promissory note interest rate	10.00%
Debt maturity date	Jan. 31, 2020
Number of common stock shares issued \| shares		799,995
Common stock price per share \| $ / shares		$ 3.25
Number of common stock shares issued, values		$ 2,600,000
Warrant to purchase shares of common stock \| shares		22,000
Proceeds from warrant exercises		$ 15,800
Conversion of debentures, value		10,000,000
Principal amount		600,000
Accrued interest		$ 97,000
Conversion of debentures into shares \| shares		233,194
Subsequent Event [Member] \| Options [Member]
Common stock price per share \| $ / shares		$ 0.26
Options to purchase shares of common stock \| shares		50,000
Proceeds from issuance of common stock		$ 13,000
Subsequent Event [Member] \| Options One [Member]
Options to purchase shares of common stock \| shares		350,000
Number of common stock paid via surrender \| shares		139,985
Subsequent Event [Member] \| Minimum [Member]
Warrant exercise price per share \| $ / shares		$ 0.50
Debt conversion price per share \| $ / shares		2.90
Subsequent Event [Member] \| Maximum [Member]
Warrant exercise price per share \| $ / shares		0.40
Debt conversion price per share \| $ / shares		$ 3.06
Subsequent Event [Member] \| Maryland Health & Wellness Center Inc [Member]
Ownership percentage			20.00%
Construction loan			$ 300,000
Loan interest rate			8.00%
Subsequent Event [Member] \| Chooze Corp [Member]
Note receivable			$ 258,000
Ownership percentage			2.70%
Subsequent Event [Member] \| Real Estate [Member]
Number of square foot \| ft²	100,000
Lease term	10 years
Subsequent Event [Member] \| Real Estate [Member] \| Cultivation and Processing Facility [Member]
Number of square foot \| ft²	60,000
GenCanna Global, Inc. [Member]
Payments to acquire subordinated secured convertible debentures				$ 30,000,000
Ownership percentage				33.00%		33.00%
Promissory note interest rate				9.00%		9.00%
GenCanna Global, Inc. [Member] \| Subsequent Event [Member]
Payments to acquire subordinated secured convertible debentures		$ 30,000,000
Ownership percentage		33.50%
Meditaurus LLC [Member] \| Subsequent Event [Member]
Ownership percentage		70.00%
Maryland Health & Wellness Center Inc [Member] \| Subsequent Event [Member]
Line of credit maturity date			Jan. 31, 2023